Metabolite | Fold change | Significance | Correlation with ICS | |||||
Control | Mild | Moderate | Severe | p-value | q-value | r | p-value | |
DHEA-S | 1 (0.69–1.45) | 0.91 (0.61–1.46) | 0.57 (0.39–0.97) | 0.23 (0.14–0.32) | 2×10−7 | 1×10−5 | −0.68 | 5×10−7 |
Cortisone | 1 (0.85–1.19) | 0.99 (0.84–1.26) | 0.91 (0.79–1.17) | 0.62 (0.53–0.8) | 2×10−4 | 0.01 | −0.45 | 0.003 |
Oleoylethanolamide | 1 (0.83–1.24) | 1.2 (0.89–1.59) | 1.3 (0.97–1.59) | 1.65 (1.32–1.91) | 0.001 | 0.01 | 0.26 | 0.09 |
22-hydroxycholesterol | 1 (0.8–1.26) | 1.33 (1.04–1.6) | 1.07 (0.86–1.33) | 1.34 (1.02–1.66) | 0.002 | 0.03 | 0.28 | 0.07 |
Methylthioadenosine | 1 (0.68–1.46) | 1.09 (0.66–1.65) | 0.89 (0.68–1.26) | 1.78 (1.16–2.4) | 0.002 | 0.03 | 0.15 | 0.37 |
Prolylhydroxyproline | 1 (0.53–1.87) | 1.55 (0.81–2.42) | 1.16 (0.61–1.95) | 0.51 (0.23–1.36) | 0.01 | 0.07 | −0.36 | 0.02 |
Pipecolate | 1 (0.73–1.27) | 0.87 (0.66–1.12) | 0.93 (0.7–1.1) | 0.78 (0.58–0.91) | 0.01 | 0.07 | −0.32 | 0.04 |
N-palmitoyltaurine | 1 (0.55–1.54) | 0.47 (0.26–1.3) | 0.7 (0.46–2.01) | 1.71 (1.28–3.17) | 0.01 | 0.07 | 0.48 | 0.002 |
α-Linolenic acid | 0.99 (0.73–1.35) | 1.67 (1.23–2.22) | 1.13 (0.92–1.63) | 1.22 (0.96–1.81) | 0.01 | 0.07 | −0.08 | 0.60 |
Phenylalanine | 1 (0.88–1.12) | 0.94 (0.82–1.09) | 1.07 (0.93–1.19) | 1.16 (1.03–1.31) | 0.01 | 0.07 | 0.10 | 0.53 |
Xanthine | 1 (0.71–1.43) | 0.96 (0.67–1.17) | 1.38 (0.91–1.62) | 1.39 (0.97–1.68) | 0.01 | 0.07 | 0.16 | 0.31 |
S1P(d18:1) | 1 (0.88–1.12) | 1.01 (0.84–1.2) | 1.18 (0.97–1.36) | 1.22 (1.02–1.4) | 0.02 | 0.09 | −0.03 | 0.83 |
Cortisol | 1.02 (0.74–1.37) | 1.06 (0.76–1.43) | 0.99 (0.72–1.46) | 0.61 (0.41–0.95) | 0.02 | 0.13 | −0.39 | 0.01 |
Arginine | 1 (0.85–1.19) | 0.96 (0.72–1.19) | 1.1 (0.97–1.28) | 1.17 (1.05–1.35) | 0.03 | 0.13 | 0.22 | 0.15 |
Taurine | 1 (0.73–1.34) | 0.85 (0.59–1.15) | 1.06 (0.79–1.5) | 1.1 (0.88–1.45) | 0.05 | 0.20 | 0.19 | 0.21 |
Oleic acid | 1.03 (0.49–1.81) | 1.88 (1.04–3.28) | 0.9 (0.42–2.02) | 1.68 (1–3) | 0.06 | 0.23 | 0.25 | 0.12 |
Dihydro-S1P(d18:0) | 1 (0.82–1.2) | 0.96 (0.77–1.25) | 1.15 (0.92–1.39) | 1.27 (1.05–1.57) | 0.06 | 0.23 | 0.12 | 0.45 |
Linoleic acid | 1 (0.66–1.44) | 1.93 (1.15–2.94) | 0.88 (0.48–1.72) | 1.41 (0.9–2.04) | 0.06 | 0.23 | 0.19 | 0.23 |
Bilirubin | 1 (0.64–1.55) | 0.91 (0.64–1.4) | 0.79 (0.53–1.21) | 0.64 (0.47–1.04) | 0.08 | 0.27 | 0.11 | 0.49 |
Uridine | 1 (0.91–1.09) | 0.91 (0.76–1.05) | 0.93 (0.85–1.04) | 1.06 (0.9–1.2) | 0.09 | 0.28 | 0.20 | 0.21 |
N-acetylcarnosine | 1 (0.61–1.56) | 0.81 (0.48–1.35) | 0.65 (0.42–0.88) | 0.68 (0.43–1.1) | 0.09 | 0.28 | 0.13 | 0.48 |
Aspartylphenylalanine | 1 (0.64–1.51) | 0.96 (0.58–1.55) | 1.14 (0.8–1.53) | 1.35 (0.91–2.03) | 0.10 | 0.29 | 0.17 | 0.27 |
Phenylacetylglutamine | 1 (0.52–1.87) | 0.45 (0.28–0.98) | 0.7 (0.44–1.31) | 1.08 (0.48–2.08) | 0.10 | 0.29 | 0.04 | 0.79 |
Data are presented as the fold-change of the median (95% CI). Displayed data were selected based upon p<0.1. The full list of all detected metabolites is provided in supplementary table E3. Median fold change and confidence intervals were estimated using 500 iterations of bootstrap resampling. ICS: inhaled corticosteroids; S1P: sphingosine-1-phosphate.